FDA Warns Amazon Over Unapproved Herpes Treatments

The U.S. Food and Drug Administration (FDA) issued a warning letter to Amazon on July 24, 2024, concerning the sale of unapproved treatments for herpes on its e-commerce platform. This action followed an investigation initiated in July 2024, during which the FDA purchased several herpes treatment products from Amazon's website. The agency's subsequent analysis revealed numerous violations of federal law, indicating that these products were being marketed and sold without the necessary FDA approval.

The warning letter specifically addresses the sale of products that are intended to diagnose, cure, mitigate, treat, or prevent disease, but have not undergone the rigorous review and approval processes mandated by the FDA. The FDA's authority to regulate drugs and medical devices is established under the Federal Food, Drug, and Cosmetic Act. This act requires that any product making therapeutic claims must be proven safe and effective before it can be legally marketed in the United States. The presence of unapproved drugs on a large retail platform like Amazon poses a significant public health risk, as consumers may be misled into using ineffective or potentially harmful treatments.

While the FDA's announcement did not name the specific products or the sellers involved, it emphasized Amazon's responsibility as a platform operator to ensure that the products listed and sold on its site comply with all applicable federal regulations. The agency has previously taken action against online marketplaces and individual sellers for distributing unapproved or misbranded drugs. The FDA's warning letter serves as a formal notification to Amazon that it must take immediate corrective actions to remove these violative products from its platform and prevent future occurrences. Failure to comply with the FDA's directives could result in further enforcement actions, including seizure of products, injunctions, and civil or criminal penalties.

This enforcement action underscores the FDA's ongoing commitment to protecting consumers from unsafe and ineffective medical products. The agency encourages consumers to report any suspected adverse events or concerns about medical products to the FDA's MedWatch program. Amazon, as one of the world's largest online retailers, plays a crucial role in the distribution of goods, and its compliance with regulatory requirements is paramount for safeguarding public health. The FDA expects Amazon to implement robust systems to vet the products offered by third-party sellers, particularly those making health-related claims, to ensure they meet federal standards for safety and efficacy.